TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Redo Biosolutions AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
510,336
|
404,749
|
424,384 |
| Financial expenses |
4,605
|
8,178
|
4,847 |
| Earnings before taxes |
103,443
|
60,766
|
56,541 |
| Total assets |
639,845
|
569,094
|
520,751 |
| Current assets |
225,652
|
201,529
|
121,865 |
| Current liabilities |
121,166
|
114,384
|
246,533 |
| Equity capital |
479,229
|
397,660
|
198,329 |
| - share capital |
20,800
|
20,800
|
20,400 |
| Employees (average) | 16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.9%
|
69.9%
|
38.1% |
| Turnover per employee | 25,297 | ||
| Profit as a percentage of turnover |
20.3%
|
15.0%
|
13.3% |
| Return on assets (ROA) |
16.9%
|
12.1%
|
11.8% |
| Current ratio |
186.2%
|
176.2%
|
49.4% |
| Return on equity (ROE) |
21.6%
|
15.3%
|
28.5% |
| Change turnover |
105,587
|
-19,635
|
136,136 |
| Change turnover % |
26%
|
-5%
|
47% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.